ORLYNE CHARLES: Open Payments
NPI 1710574868 · BARTOW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,980 in 108 payments from 15 companies in 2025. Trend: 2023 $2,259 · 2024 $2,517 · 2025 $1,980
Food & beverage: $1,980
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $318 |
| E.R. Squibb & Sons, L.L.C. | 13 | $302 |
| Teva Pharmaceuticals USA, Inc. | 24 | $270 |
| Otsuka America Pharmaceutical, Inc. | 28 | $255 |
| Neurocrine BioSciences, Inc. | 8 | $187 |
| Alkermes, Inc. | 9 | $163 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| EVOKE PHARMA, INC. | 1 | $81 |
| Lundbeck LLC | 2 | $36 |
Products named: INVEGA, COBENFY, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, Auvelity, UZEDY, REXULTI.
Industry payments across FL — which companies pay providers there.
